Development of anti-SARS-CoV-2 vaccines
- Funded by ANR
- Total publications:244 publications
Grant number: Unknown
Grant search
Key facts
Disease
COVID-19Funder
ANRPrincipal Investigator
. Véronique GODOTResearch Location
FranceLead Research Institution
Institut Mondor de Recherche Biomédicale - IMRBResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The DC-CoVaC project, coordinated by Véronique Godot (UMR U955 Mondor Institute for Biomedical Research - IMRB), aims to test the immunogenicity and the preventive effect of a combination of two vaccine platforms in phase 1 to 3 of clinical development. Their approach aims to induce a polyepitopic T and B cell response. The vaccines will be tested in two preclinical models in order to study in vivo human immune responses induced by vaccines, and to demonstrate the protective effect of these vaccines.
Publicationslinked via Europe PMC
Last Updated:5 days ago
View all publications at Europe PMC